UBA5 基因突变致早发性癫痫性脑病临床特征与遗传学分析

doi:10.6040/j.issn.1671-7554.0.2021.1453

摘要/Abstract

摘要： 目的探讨早发癫痫性脑病患者的临床特征和基因突变情况,为疾病诊断提供依据。方法应用二代测序技术对 1 例早发癫痫性脑病患者的外周血标本进行全外显子组测序(WES)检测,发现可疑致病位点后利用 Sanger 测序对患者及其父母进行验证分析。结果本次检出 UBA5 基因 c.214C>T(p.R72C)杂合变异(NM_024818)和 c.1141_1144delTCTG 杂合变异(NM_024818),均提示为疑似致病性变异。结论 UBA5 基因突变引起的早发性癫痫性脑病非常罕见,UBA5 基因可能是早发性癫痫性脑病患者的致病原因,为早发癫痫性脑病遗传咨询提供了依据。

关键词: 早发癫痫性脑病, 发育迟滞, UBA5 基因

Abstract: Objective To explore the clinical characteristics, gene mutations and etiology of patients with early onset epileptic encephalopathy(EOEE)so as to provide reference for the diagnosis. Methods Next-generation sequencing technology was performed for exome sequencing in the genomes of 1 EOEE patient. Suspected mutations were validated with Sanger sequencing in the patient and parents. Results The c.214C>T(p.R72C)heterozygous variation(NM_024818)and c.1141_1144delTCTG chimeric variation(NM_024818)were detected in UBA5 gene, suggesting possible pathogenicity. Conclusion EOEE induced by mutations in the UBA5 gene is very rare. Combined with the previously reported UBA5 cases, mutations in the UBA5 gene may be the etiology of EOEE, which provide a basis for the genetic counselling of the disease.

Key words: Early onset epileptic encephalopathy, Developmental delay, UBA5 gene

中图分类号:

R748

李军,李保敏,杨璐. UBA5 基因突变致早发性癫痫性脑病临床特征与遗传学分析[J]. 山东大学学报 (医学版), 2022, 60(8): 58-62.

LI JUN, LI Baomin, YANG LU. Clinical characteristics and genetic analysis of early onset epileptic encephalopathy induced by UBA5 gene mutation[J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 58-62.

参考文献

[1] Daniel J, Liebau E. The ufm1 cascade [J]. Cells, 2014, 3(2): 627-638.
[2] Komatsu M, Chiba T, Tatsumi K, et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier [J]. EMBO J, 2004, 23(9): 1977-1986.
[3] Tatsumi K, Sou YS, Tada N, et al. A novel type of E3 ligase for the Ufm1 conjugation system [J]. J Biol Chem, 2010, 285(8): 5417-5427.
[4] Dou T, Gu S, Liu J, et al. Isolation and characterization of ubiquitin-activating enzyme E1-domain containing 1, UBE1DC1 [J]. Mol Biol Rep, 2005, 32(4): 265-271.
[5] Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics(ACMG)[J]. Genet Med, 2021, 23(11): 2029-2037.
[6] Gerakis Y, Quintero M, Li H, et al. The UFMylation System in Proteostasis and Beyond [J]. Trends Cell Biol, 2019, 29(12): 974-986.
[7] van der Veen AG, Ploegh HL. Ubiquitin-like proteins [J]. Annu Rev Biochem, 2012, 81: 323-57.
[8] Cappadocia L, Lima CD. Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism [J]. Chem Rev, 2018, 118(3): 889-918.
[9] Colin E, Daniel J, Ziegler A, et al. Biallelic variants in UBA5 reveal that disruption of the UFM1 cascade can result in early-onset encephalopathy [J]. Am J Hum Genet, 2016, 99(3): 695-703.
[10] Duan R, Shi Y, Yu L, et al. UBA5 Mutations Cause a New Form of Autosomal Recessive Cerebellar Ataxia [J]. PLoS One, 2016, 11(2): e0149039. doi: 10.1371/journal.pone.0149039.
[11] Muona M, Ishimura R, Laari A, et al. Biallelic Variants in UBA5 Link Dysfunctional UFM1 Ubiquitin-like Modifier Pathway to Severe Infantile-Onset Encephalopathy [J]. Am J Hum Genet, 2016, 99(3): 683-694.
[12] Nahorski MS, Maddirevula S, Ishimura R, et al. Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development [J]. Brain, 2018, 141(7): 1934-1945.
[13] Daida A, Hamano SI, Ikemoto S, et al. Biallelic loss-of-function UBA5 mutations in a patient with intractable West syndrome and profound failure to thrive [J]. Epileptic Disord, 2018, 20(4): 313-318.
[14] Mignon-Ravix C, Milh M, Kaiser CS, et al. Abnormal function of the UBA5 protein in a case of early developmental and epileptic encephalopathy with suppression-burst [J]. Hum Mutat, 2018, 39(7): 934-938.
[15] Zheng M, Gu X, Zheng D, et al. UBE1DC1, an ubiquitin-activating enzyme, activates two different ubiquitin-like proteins [J]. J Cell Biochem, 2008, 104(6): 2324-2334.
[16] Padala P, Oweis W, Mashahreh B, et al. Novel insights into the interaction of UBA5 with UFM1 via a UFM1-interacting sequence [J]. Sci Rep, 2017, 7(1): 508.
[17] Habisov S, Huber J, Ichimura Y, et al. Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5(UBA5)Required for Binding to Ubiquitin-like Proteins and Ufmylation [J]. J Biol Chem, 2016, 291(17): 9025-9041.
[18] Kumar M, Padala P, Fahoum J, et al. Structural basis for UFM1 transfer from UBA5 to UFC1 [J]. Nat Commun, 2021, 12(1): 5708.
[19] Arnadottir GA, Jensson BO, Marelsson S E, et al. Compound heterozygous mutations in UBA5 causing early-onset epileptic encephalopathy in two sisters [J]. BMC Med Genet, 2017, 18(1): 103.
[20] Cabrera-Serrano M, Coote DJ, Azmanov D, et al. A homozygous UBA5 pathogenic variant causes a fatal congenital neuropathy [J]. J Med Genet, 2020, 57(12): 835-842.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

本文评价

推荐阅读 10

[1]	索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1 -6 .
[2]	马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32 -37 .
[3]	张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7 -14 .
[4]	付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24 -31 .
[5]	龙婷婷,谢明,周璐,朱俊德. Noggin蛋白对小鼠脑缺血再灌注损伤后学习和记忆能力与齿状回结构的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 15 -23 .
[6]	李宁,李娟,谢艳,李培龙,王允山,杜鲁涛,王传新. 长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 38 -46 .
[7]	徐玉香,刘煜东,张蓬,段瑞生. 101例脑小血管病患者脑微出血危险因素的回顾性分析[J]. 山东大学学报 (医学版), 2020, 1(7): 67 -71 .
[8]	丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60 -66 .
[9]	肖娟,肖强,丛伟,李婷,丁守銮,张媛,邵纯纯,吴梅,刘佳宁,贾红英. 两种甲状腺超声数据报告系统诊断效能的比较[J]. 山东大学学报 (医学版), 2020, 1(7): 53 -59 .
[10]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .